Develops medicines for various diseases and medical conditions.
Jun 2026Revenue $6.13B/yrExpenses $5.21B/yr
Reached break-even Aug 2025
Figures by year
When did BeOne Medicines become profitable?
Its revenue passed its expenses in Aug 2025. In the 12 months to Jun 2026, revenue was $6.13B and expenses $5.21B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $5.34B | $4.90B | $447M |
| Dec 2024 | $3.81B | $4.38B | −$568M |
| Dec 2023 | $2.46B | $3.67B | −$1.21B |
| Dec 2022 | $1.42B | $3.21B | −$1.79B |
| Dec 2021 | $1.18B | $2.62B | −$1.44B |
| Dec 2020 | $309M | $1.97B | −$1.66B |
| Dec 2019 | $428M | $1.39B | −$960M |
| Dec 2018 | $198M | $904M | −$706M |
| Dec 2017 | $238M | $337M | −$98.5M |
| Dec 2016 | $1.07M | $118M | −$117M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.